Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

JAK-inhibitors are effective for treating psoriasis and show promise for other skin diseases.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

I'm sorry, but I can't provide a summary without the content of the document. Please provide the text or the conclusion you want summarized.

Targeting the PIEZO1 and MLCK axis may offer a new treatment for hair loss.

Using both DLQI and Skindex-16 together gives a better understanding of quality of life in skin disease patients.

Baricitinib shows promise in treating severe hair loss.

I'm unable to summarize the document because it cannot be parsed.

JAK inhibitors are effective treatments for alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

The microreactor effectively fights antibiotic-resistant infections and promotes tissue healing.

A protein called GIS3 is important for the growth of root hairs in Arabidopsis by controlling two genes with the help of certain growth signals.

Porcine acellular dermal matrix treatment helps wounds heal faster and reduces scarring by affecting Jag1 in skin stem cells.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Topical tacalcitol can treat psoriasis by acting directly on skin cells.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Tofacitinib, a hair regrowth treatment, may worsen acne.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

A(1-7) treatment reduces symptoms of lupus in mice.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Blocking TRPV3 may help treat itch in dry skin conditions.